Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Reducing Dyskinesia in Parkinson's Disease With Omega-3 Fatty Acids (RLID-PD)

This study has been completed.
Oregon Health and Science University
Information provided by (Responsible Party):
VA Office of Research and Development Identifier:
First received: March 16, 2012
Last updated: June 28, 2016
Last verified: June 2016